Last Update

This profile was last updated on 8/14/2015 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Mike Suesserman?

Mike Suesserman

Vice Presidents of US Marketing

Pfizer Inc

HQ Phone:  (212) 733-2323

Direct Phone: (212) ***-****direct phone

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Pfizer Inc

235 E 42ND ST

New York City, New York, 10017

United States

Company Description

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care produc...more

Find other employees at this company (72,706)

Background Information

Employment History

Managing Director, Early Product Commercialization

MSI Consultancy Ltd


Managing Director, Cello Health Early Product Commercialization

Cello Health Insight


Senior Associate

Gerson Lehrman Group Inc


President and Chief Executive Officer

Clarity Consulting Partners


Senior Marketing Manager Lipitor Team.

Salesforce.Com Inc


President

Hark Health LLC


Global Team Leader

Lipitor


Affiliations

Repros Therapeutics Inc.

Board Member


benzinga partners

Board Member


RegionalCare Hospital Partners Inc

Board Member


Education

Bachelor's degree

Economics

Clark University


MBA

Kelley School of Business at Indiana University


Web References(19 Total References)


Repros Therapeutics

Mike Suesserman
Director Mike Suesserman Mr. Suesserman was elected a director in December 2013 by the other members of the Board. Mr. Suesserman is currently the Managing Director of Cello Health, PLC and brings over two decades of experience in launching, building and developing pharmaceutical marketing platforms, including those for megabrands Lipitor and Viagra. His breadth of experience in commercializing pharmaceuticals also spans the entire product lifecycle, including portfolio prioritization, product development, US and Global product management, life-cycle extension as well as reimbursement and market access. Additionally, Mr. Suesserman also has extensive experience in a number of therapeutic areas, particularly urology and was responsible for the commercial development of Pfizer's Sexual Health franchise strategy, re-positioning and re-launching Viagra in the face of the global introductions of Cialis and Levitra, and creating access and formulary placement for Detrol LA in the US. Mr. Suesserman spent 18 years of his career at Pfizer, Inc. in roles of increasing responsibility, including US Team Leader for Lipitor, Global Team Leader for Lipitor and VP of Managed Markets Group in the US. He received his Bachelor's degree in Economics from Clark University and his MBA from the Kelley School of Business at Indiana University.


http://www.sec.gov/Archives/edgar/data/897075/0001144204-15-023283.txt

Our board of directors has nominated and urges you to vote for the election of Joseph S. Podolski, our President and Chief Executive Officer, Daniel F. Cain, Nola E. Masterson, Saira Ramasastry, Michael Suesserman and Michael G. Wyllie, Ph.D., DSC, all of whom have been nominated to serve as directors until the next annual meeting of stockholders or until their successors are duly elected and qualified.
Michael Suesserman. Michael Suesserman. Mr. Suesserman was elected a director in December 2013 by the other members of the Board following their decision to bring in additional members with appropriate experience. Mr. Suesserman brings over 20 years of experience in developing, launching and building pharmaceutical brands, including such megabrands as Lipitor, Viagra, and Detrol LA. He is currently Managing Director of Cello Health Consulting, providing advisory services to the global life sciences industry. He spent 18 years at Pfizer, in roles of increasing responsibility. He was the US and then Global Team Leader for Lipitor, was responsible for the global urology franchise, and also held the position of VP, Managed Markets Group in the US. In addition to overall commercial expertise, Mr. Suesserman has extensive experience in a number of therapeutic areas including urology. He was responsible for the commercial development of Pfizer's Urology/Sexual Health franchise strategy, re-positioning and re-launching Viagra in the face of the global introductions of Cialis and Levitra, and creating access and formulary placement for Detrol LA in the US. Mr. Suesserman holds an M.B.A. from Kelley School of Business at Indiana University and earned his Bachelor's degree in Economics from Clark University. Mr. Suesserman provides us with the benefit of his more than 20 years of experience in the launching, building and developing pharmaceutical marketing platforms both in the U.S. and globally. The board of directors has determined that Mr. Cain, Ms. Masterson, Ms. Ramasastry, Mr. Suesserman and Dr. Wyllie are all "independent" as independence is defined under the listing standards for The NASDAQ Stock Market.


http://www.benzinga.com/news/13/12/4170817/repros-adds-marketing-and-commercialization-expertise-to-board-of-directors

Repros Therapeutics (Nasdaq: RPRX) today announced it has added Michael Suesserman to the Company's Board of Directors.
Michael Suesserman is currently Managing Director, Cello Health Consulting, providing advisory services to the global life sciences industry. Mike brings over two decades of experience in launching, building, and developing pharmaceutical marketing platforms, including those for the megabrands Lipitor and Viagra. Mike's breadth of experience in commercializing pharmaceuticals spans the entire product lifecycle, including portfolio prioritization, product development, US and Global product management, life-cycle extension as well as reimbursement and market access. He spent 18 years at Pfizer, in roles of increasing responsibility. He was the US and then Global Team Leader for Lipitor, was responsible for the global urology franchise and also held the position of VP, Managed Markets Group in the US. In addition to overall commercial expertise, Mike has extensive experience in a number of therapeutic areas, particularly urology. He was responsible for the commercial development of Pfizer's Sexual Health franchise strategy, re-positioning and re-launching Viagra in the face of the global introductions of Cialis and Levitra, and creating access and formulary placement for Detrol LA in the US. Mike holds an MBA from Kelley School of Business at Indiana University and earned his Bachelor's degree in Economics from Clark University. Joseph Podolski, President and CEO of Repros commented, "We are fortunate to have Mike join the Repros Board of Directors. He further noted, "Assuming Androxal attains US FDA approval, we believe it has the potential of the 'megabrands' Mike has been intimately associated with, driving these drugs to commercial success."


http://houston.citybizlist.com/article/repros-therapeutic-appoints-michael-suesserman-board-0

Repros Therapeutic Appoints Michael Suesserman To Board
December 20, 2013 Michael Suesserman Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced it has added Michael Suesserman to the Company's Board of Directors. Michael Suesserman is currently Managing Director, Cello Health Consulting, providing advisory services to the global life sciences industry. Mike brings over two decades of experience in launching, building, and developing pharmaceutical marketing platforms, including those for the megabrands Lipitor and Viagra. Mike's breadth of experience in commercializing pharmaceuticals spans the entire product lifecycle, including portfolio prioritization, product development, US and Global product management, life-cycle extension as well as reimbursement and market access. He spent 18 years at Pfizer, in roles of increasing responsibility. He was the US and then Global Team Leader for Lipitor, was responsible for the global urology franchise and also held the position of VP, Managed Markets Group in the US. In addition to overall commercial expertise, Mike has extensive experience in a number of therapeutic areas, particularly urology. He was responsible for the commercial development of Pfizer's Sexual Health franchise strategy, re-positioning and re-launching Viagra in the face of the global introductions of Cialis and Levitra, and creating access and formulary placement for Detrol LA in the US. Mike holds an MBA from Kelley School of Business at Indiana University and earned his Bachelor's degree in Economics from Clark University. Joseph Podolski, President and CEO of Repros commented, "We are fortunate to have Mike join the Repros Board of Directors. He further noted, "Assuming Androxal attains US FDA approval, we believe it has the potential of the 'megabrands' Mike has been intimately associated with, driving these drugs to commercial success."


Repros Adds Marketing and Commercialization Expertise to Board of Directors (NASDAQ:RPRX)

Michael Suesserman
Michael Suesserman is currently Managing Director, Cello Health Consulting , providing advisory services to the global life sciences industry. Mike brings over two decades of experience in launching, building, and developing pharmaceutical marketing platforms, including those for the megabrands Lipitor and Viagra. Mike's breadth of experience in commercializing pharmaceuticals spans the entire product lifecycle, including portfolio prioritization, product development, US and Global product management, life-cycle extension as well as reimbursement and market access. He spent 18 years at Pfizer, in roles of increasing responsibility. He was the US and then Global Team Leader for Lipitor, was responsible for the global urology franchise and also held the position of VP, Managed Markets Group in the US. In addition to overall commercial expertise, Mike has extensive experience in a number of therapeutic areas, particularly urology. He was responsible for the commercial development of Pfizer's Sexual Health franchise strategy, re-positioning and re-launching Viagra in the face of the global introductions of Cialis and Levitra, and creating access and formulary placement for Detrol LA in the US. Mike holds an MBA from , President and CEO of Repros commented, "We are fortunate to have Mike join the Repros Board of Directors. His unique skill set provides Repros with important sales and marketing insight to help us develop our strategy to maximize shareholder returns for our lead product Androxal. He further noted, "Assuming Androxal attains US FDA approval, we believe it has the potential of the 'megabrands' Mike has been intimately associated with, driving these drugs to commercial success."


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory